Bonesupport develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months. Their products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery. The company was listed in Stockholm in 2017. Industrifonden exited in 2022. ↗